Record Information
Version1.0
Creation Date2016-05-19 01:46:34 UTC
Update Date2026-05-14 16:38:40 UTC
Accession NumberCHEM004476
Identification
Common NameNitric oxide
ClassSmall Molecule
DescriptionNitric oxide (NO) is a compound with an average molecular weight of 30.01 g/mol. Nitric oxide belongs to the other non-metal oxides, a subclass of other non-metal organides within the inorganic compounds. It is used in Polyamide and is found in unclassified respiratory system products within healthcare, pharmaceuticals, and veterinary products. Recorded exposure routes include topical and respiratory, with inhalation supported by literature (PMC11770536). Biologically, it serves as a neurotransmitter (PMC2745337, PMC9556195), inhibitor (PMC11429291), antimicrobial agent (PMC4160367, PMC6322413, PMC9465324), and biomarker (PMC6617305). It targets six proteins, including Nitric oxide synthase 3 (NOS3), Indoleamine 2,3-dioxygenase 1 (IDO1), Metallothionein-1A (MT1A), and Guanylate cyclase soluble subunit alpha-2 (GUCY1A2). The compound is associated with various health effects, including inflammation (PMC10837992, PMC11910329, PMC2885079, PMC3867356, PMC4739797), cancer (PMC3853740, PMC5362166, PMC9784116), rheumatoid arthritis (PMC3853740, PMC6264366), blood pressure (PMC11678264), thrombosis (PMC4739797), diabetic retinopathy (PMC3351417), pain (PMC9313384), methemoglobinemia (PMC1392223), and disease (PMC2929206). It is linked to an increase in asthma (PMC10948772), epilepsy (PMC4428026, PMC6213719), and interstitial cystitis (PMC3989437), as well as Hypogonadotropic hypogonadism (PMC13246832). Conversely, it is associated with a decrease in atherosclerosis (PMC2965309). Therapeutic effects are noted for hypertension (PMC4217569), glaucoma (PMC11013077), colon cancer (PMC3572206), and blood pressure (PMC13143078, PMC9479141), inflammation (PMC12988469, PMC6835591, PMC9479141), and thrombosis (PMC13143078, PMC6835591, PMC9479141). It is a treatment for thrombosis (PMC12194899). Additionally, it is a biomarker of inflammation (PMC13279942), asthma (PMC9170864), and liver cirrhosis (PMC12072035), and is increased in the blood of individuals with depression (PMC11563972).
Contaminant Sources
  • Clean Air Act Chemicals
  • FooDB Chemicals
  • HPV EPA Chemicals
  • OSHA Hazardous Chemicals
Contaminant Type
  • Human Neurotoxin
Chemical Structure
Thumb
Synonyms
ValueSource
(NO)(.)ChEBI
[NO]ChEBI
EDRFChEBI
Endothelium-derived relaxing factorChEBI
Mononitrogen monoxideChEBI
Monoxido de nitrogenoChEBI
Monoxyde d'azoteChEBI
Nitrogen monooxideChEBI
Nitrogen monoxideChEBI
NitrosylChEBI
NOChEBI
(.)NOChEBI
NO(.)ChEBI
Oxido de nitrogeno(II)ChEBI
Oxido nitricoChEBI
Oxyde azotiqueChEBI
Oxyde nitriqueChEBI
Stickstoff(II)-oxidChEBI
StickstoffmonoxidChEBI
INOmaxKegg
Nitrogen oxideHMDB
Nitrogen protoxideHMDB
Nitrosyl hydrideHMDB
Nitrosyl radicalHMDB
Nitroxide radicalHMDB
NitroxylHMDB
Endogenous nitrate vasodilatorMeSH, HMDB
Monoxide, nitrogenMeSH, HMDB
Nitric oxide, endothelium derivedMeSH, HMDB
Nitric oxide, endothelium-derivedMeSH, HMDB
Monoxide, mononitrogenMeSH, HMDB
Vasodilator, endogenous nitrateMeSH, HMDB
Endothelium-derived nitric oxideMeSH, HMDB
Nitrate vasodilator, endogenousMeSH, HMDB
Oxide, nitricMeSH, HMDB
Chemical FormulaNO
Average Molecular Mass30.006 g/mol
Monoisotopic Mass29.998 g/mol
CAS Registry Number10102-43-9
IUPAC Namenitroso
Traditional Namenitric oxide
SMILES[N]=O
InChI IdentifierInChI=1S/NO/c1-2
InChI KeyMWUXSHHQAYIFBG-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of inorganic compounds known as other non-metal oxides. These are inorganic compounds containing an oxygen atom of an oxidation state of -2, in which the heaviest atom bonded to the oxygen belongs to the class of 'other non-metals'.
KingdomInorganic compounds
Super ClassHomogeneous non-metal compounds
ClassOther non-metal organides
Sub ClassOther non-metal oxides
Direct ParentOther non-metal oxides
Alternative Parents
Substituents
  • Other non-metal oxide
  • Inorganic oxide
Molecular FrameworkNot Available
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
Pathways
NameSMPDB LinkKEGG Link
Arginine and Proline MetabolismSMP0000020 Not Available
Prolidase Deficiency (PD)SMP0000207 Not Available
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)SMP0000362 Not Available
Hyperprolinemia Type IISMP0000360 Not Available
Hyperprolinemia Type ISMP0000361 Not Available
Prolinemia Type IISMP0000208 Not Available
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)SMP0000188 Not Available
Ornithine Aminotransferase Deficiency (OAT Deficiency)SMP0000363 Not Available
Creatine Deficiency, Guanidinoacetate Methyltransferase DeficiencySMP0000504 Not Available
Hyperornithinemia with Gyrate Atrophy (HOGA)SMP0000505 Not Available
Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH-syndrome)SMP0000506 Not Available
L-Arginine:Glycine Amidinotransferase DeficiencySMP0000507 Not Available
Clemastine H1-Antihistamine Immune Response Action PathwaySMP0058891 Not Available
Nitric Oxide Signaling PathwaySMP0063777 Not Available
Ion Channels and Their Functional Role in Vascular EndotheliumSMP0063778 Not Available
Succinate SignallingSMP0083294 Not Available
Succinate Signalling During InflammationSMP0084634 Not Available
Sildenafil Action PathwaySMP0124685 Not Available
Nitroglycerin Action PathwaySMP0124692 Not Available
Succinate Immunometabolism PathwaySMP0124909 Not Available
Citrate Immunometabolism PathwaySMP0124912 Not Available
Isosorbide Mononitrate Action PathwaySMP0125275 Not Available
Isosorbide Dinitrate Action PathwaySMP0125279 Not Available
Caffeine Vasodilation Action PathwaySMP0125283 Not Available
T Cell ExhaustionSMP0125467 Not Available
Immunometabolism Pathway (Bacterial Activation)SMP0125484 Not Available
Anti-inflammatory pathwaySMP0125485 Not Available
Immunometabolism Pathway (Viral Activation)SMP0125488 Not Available
Viral SepsisSMP0125490 Not Available
Bacterial SepsisSMP0125493 Not Available
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)SMP0125623 Not Available
Hyperprolinemia Type IISMP0125624 Not Available
Hyperprolinemia Type ISMP0125626 Not Available
Prolinemia Type IISMP0125627 Not Available
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)SMP0125628 Not Available
Ornithine Aminotransferase Deficiency (OAT Deficiency)SMP0125629 Not Available
Hyperornithinemia with Gyrate Atrophy (HOGA)SMP0125630 Not Available
Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH-syndrome)SMP0125633 Not Available
L-Arginine:Glycine Amidinotransferase DeficiencySMP0125634 Not Available
Methylnaltrexone Opioid Antagonist Action PathwaySMP0126308 Not Available
Naloxegol Action PathwaySMP0126335 Not Available
Naldemedine Opioid Antagonist Action PathwaySMP0126337 Not Available
Trimebutine M3 Receptor Intestine Relaxation Action PathwaySMP0126338 Not Available
Alvimopan Opioid Antagonist Action PathwaySMP0126339 Not Available
Clemastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0126421 Not Available
Doxylamine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0126731 Not Available
Nitric Oxide Drug Metabolism Action PathwaySMP0142892 Not Available
Mirtazapine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174980 Not Available
Dexbrompheniramine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174981 Not Available
Triprolidine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174982 Not Available
Cyproheptadine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174983 Not Available
Hydroxyzine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174984 Not Available
Cinnarizine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174985 Not Available
Azatadine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174986 Not Available
Meclizine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174987 Not Available
Carbinoxamine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174988 Not Available
Tripelennamine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174989 Not Available
Brompheniramine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174990 Not Available
Ketotifen H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174991 Not Available
Promethazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174992 Not Available
Mequitazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174993 Not Available
Diphenhydramine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174994 Not Available
Emedastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174995 Not Available
Cyclizine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174996 Not Available
Alimemazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174997 Not Available
Phenindamine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174998 Not Available
Pheniramine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0174999 Not Available
Methapyrilene H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175000 Not Available
Levocetirizine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175001 Not Available
Mepyramine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175002 Not Available
Alcaftadine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175003 Not Available
Antazoline H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175004 Not Available
Chloropyramine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175005 Not Available
Dimetindene H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175006 Not Available
Acrivastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175007 Not Available
Ebastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175008 Not Available
Oxatomide H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175009 Not Available
Dexchlorpheniramine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175010 Not Available
Bepotastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175011 Not Available
Buclizine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175012 Not Available
Methdilazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175013 Not Available
Diphenylpyraline H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175014 Not Available
Bromodiphenhydramine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175015 Not Available
Olanzapine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175016 Not Available
Clozapine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175017 Not Available
Doxepin H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175018 Not Available
Orphenadrine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175019 Not Available
Quetiapine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175020 Not Available
Isothipendyl H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175022 Not Available
Chlorcyclizine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175023 Not Available
Bilastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175024 Not Available
Rupatadine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175025 Not Available
Thonzylamine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175026 Not Available
Propiomazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175027 Not Available
Deptropine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175028 Not Available
Cetirizine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175029 Not Available
Loratadine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175030 Not Available
Fexofenadine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175031 Not Available
Desloratadine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175032 Not Available
Terfenadine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175033 Not Available
Astemizole H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175034 Not Available
Olopatadine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175035 Not Available
Azelastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175036 Not Available
Levocabastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175037 Not Available
Mizolastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175038 Not Available
Epinastine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175039 Not Available
Dimenhydrinate H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175041 Not Available
Chlorpheniramine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175042 Not Available
Mianserin H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175043 Not Available
Esmirtazapine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175044 Not Available
Dimetotiazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175045 Not Available
Dexchlorpheniramine maleate H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175046 Not Available
GSK-1004723 H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175047 Not Available
Ziprasidone H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175049 Not Available
Promazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175050 Not Available
Trazodone H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175051 Not Available
Clofedanol H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175053 Not Available
Chlorprothixene H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175054 Not Available
Chlorpromazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175059 Not Available
Zuclopenthixol H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175061 Not Available
Butriptyline H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175063 Not Available
Cariprazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175064 Not Available
Benzquinamide H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175067 Not Available
Aceprometazine H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175068 Not Available
Aripiprazole lauroxil H1-Antihistamine Blood Vessel Constriction Action PathwaySMP0175069 Not Available
VEGF SignalingSMP0524112 Not Available
Sphingolipid Signaling (Receptor)SMP0524344 Not Available
Apelin SignalingSMP0642520 Not Available
Relaxin I Signaling PathwaySMP0689895 Not Available
ApplicationsNot Available
Biological Roles
Chemical RolesNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
logP-0.35ChemAxon
pKa (Strongest Basic)-2.9ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area34.14 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity2.89 m³·mol⁻¹ChemAxon
Polarizability1.69 ųChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-001i-9000000000-d182bfca83d886821e6dSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-001i-9000000000-8a2dd9da1fc114d013b3Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-001i-9000000000-8a2dd9da1fc114d013b3Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-001i-9000000000-8a2dd9da1fc114d013b3Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-004i-9000000000-e998110984a05853a05dSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-004i-9000000000-e998110984a05853a05dSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-004i-9000000000-e998110984a05853a05dSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-001i-9000000000-4faa0e3c79683567bab0Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-001i-9000000000-4faa0e3c79683567bab0Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-001i-9000000000-4faa0e3c79683567bab0Spectrum
Toxicity Profile
Route of ExposureNot Available
Mechanism of ToxicityNot Available
MetabolismNot Available
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)Not Available
Uses/SourcesNot Available
Minimum Risk LevelNot Available
Health EffectsNot Available
SymptomsNot Available
TreatmentNot Available
Concentrations
Not Available
DrugBank IDDB00435
HMDB IDHMDB0032439
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNITRIC-OXIDE
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkNitric oxide
Chemspider ID127983
ChEBI ID16480
PubChem Compound ID145068
Kegg Compound IDC00533
YMDB IDYMDB00982
ECMDB IDECMDB03378
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. Morabito, Paul; Heicklen, Julian. Disproportionation to combination ratios of alkoxy radicals with nitric oxide. Journal of Physical Chemistry (1985), 89(13), 2914-16.
2. Atakisi O, Oral H, Atakisi E, Merhan O, Metin Pancarci S, Ozcan A, Marasli S, Polat B, Colak A, Kaya S: Subclinical mastitis causes alterations in nitric oxide, total oxidant and antioxidant capacity in cow milk. Res Vet Sci. 2010 Aug;89(1):10-3. doi: 10.1016/j.rvsc.2010.01.008. Epub 2010 Feb 4.